Trial Outcomes & Findings for Optic Nerve Head Structural Response to IOP Elevation in Patients With Keratoconus (NCT NCT03560609)

NCT ID: NCT03560609

Last Updated: 2025-01-29

Results Overview

Determination of tissue deformation will be obtained from OCT images.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

3 participants

Primary outcome timeframe

1 Day

Results posted on

2025-01-29

Participant Flow

This study was terminated due to the departure of the Principal Investigator from the Sponsoring institution. 3 participants were enrolled in the study; none of these participants were assessed for outcome measures. No participants (n=0) were enrolled into the "Subjects with Glaucoma" arm.

Participant milestones

Participant milestones
Measure
Subjects With Keratoconus
Individuals with keratoconus.
Subjects With Glaucoma
Individuals with glaucoma.
Overall Study
STARTED
3
0
Overall Study
COMPLETED
0
0
Overall Study
NOT COMPLETED
3
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Subjects With Keratoconus
Individuals with keratoconus.
Subjects With Glaucoma
Individuals with glaucoma.
Overall Study
Study terminated due to departure of Principal Investigator from Sponsoring institution
3
0

Baseline Characteristics

Optic Nerve Head Structural Response to IOP Elevation in Patients With Keratoconus

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Subjects With Keratoconus
n=3 Participants
Individuals with keratoconus.
Subjects With Glaucoma
Individuals with glaucoma.
Total
n=3 Participants
Total of all reporting groups
Age, Continuous
38.66 years
STANDARD_DEVIATION 4.714 • n=5 Participants
38.66 years
STANDARD_DEVIATION 4.714 • n=5 Participants
Sex: Female, Male
Female
2 Participants
n=5 Participants
2 Participants
n=5 Participants
Sex: Female, Male
Male
1 Participants
n=5 Participants
1 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
2 Participants
n=5 Participants
2 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
White
1 Participants
n=5 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
1 Participants
n=5 Participants
Region of Enrollment
United States
3 participants
n=5 Participants
3 participants
n=5 Participants

PRIMARY outcome

Timeframe: 1 Day

Population: This study was terminated due to the departure of the Principal Investigator from the Sponsoring institution. N=3 participants were enrolled in the study in the "Subjects with Keratoconus" arm, N=0 participants were enrolled in the "Subjects with Glaucoma". N=0 participants were assessed for outcome measures prior to study closure.

Determination of tissue deformation will be obtained from OCT images.

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: 1 Day

Population: This study was terminated due to the departure of the Principal Investigator from the Sponsoring institution. N=3 participants were enrolled in the study in the "Subjects with Keratoconus" arm, N=0 participants were enrolled in the "Subjects with Glaucoma". N=0 participants were assessed for outcome measures prior to study closure.

Determination of tissue deformation will be obtained from OCT images.

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: 1 Day

Population: This study was terminated due to the departure of the Principal Investigator from the Sponsoring institution. N=3 participants were enrolled in the study in the "Subjects with Keratoconus" arm, N=0 participants were enrolled in the "Subjects with Glaucoma". N=0 participants were assessed for outcome measures prior to study closure.

Obtained via OCT images - measure is from baseline to time of measurement during administration of elevated intraocular pressure.

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: 1 Day

Population: This study was terminated due to the departure of the Principal Investigator from the Sponsoring institution. N=3 participants were enrolled in the study in the "Subjects with Keratoconus" arm, N=0 participants were enrolled in the "Subjects with Glaucoma". N=0 participants were assessed for outcome measures prior to study closure.

Obtained via OCT images - measure is from baseline to time of measurement during administration of elevated intraocular pressure.

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: 1 Day

Population: This study was terminated due to the departure of the Principal Investigator from the Sponsoring institution. N=3 participants were enrolled in the study in the "Subjects with Keratoconus" arm, N=0 participants were enrolled in the "Subjects with Glaucoma". N=0 participants were assessed for outcome measures prior to study closure.

Obtained via OCT images - measure is from baseline to time of measurement during administration of elevated intraocular pressure.

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: 1 Day

Population: This study was terminated due to the departure of the Principal Investigator from the Sponsoring institution. N=3 participants were enrolled in the study in the "Subjects with Keratoconus" arm, N=0 participants were enrolled in the "Subjects with Glaucoma". N=0 participants were assessed for outcome measures prior to study closure.

Obtained via OCT images - measure is from baseline to time of measurement during administration of elevated intraocular pressure.

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: 1 Day

Population: This study was terminated due to the departure of the Principal Investigator from the Sponsoring institution. N=3 participants were enrolled in the study in the "Subjects with Keratoconus" arm, N=0 participants were enrolled in the "Subjects with Glaucoma". N=0 participants were assessed for outcome measures prior to study closure.

Obtained via OCT images - measure is from baseline to time of measurement during administration of elevated intraocular pressure.

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: 1 Day

Population: This study was terminated due to the departure of the Principal Investigator from the Sponsoring institution. N=3 participants were enrolled in the study in the "Subjects with Keratoconus" arm, N=0 participants were enrolled in the "Subjects with Glaucoma". N=0 participants were assessed for outcome measures prior to study closure.

Obtained via OCT images - measure is from baseline to time of measurement during administration of elevated intraocular pressure.

Outcome measures

Outcome data not reported

Adverse Events

Subjects With Keratoconus

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Subjects With Glaucoma

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jamika Singleton-Garvin

NYU Langone Health

Phone: (212) 263-2573

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place